does semaglutide cause kidney problems FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators Long-term kidney outcomes of semaglutide
Description
Medication adherence was higher among younger patients (OR = 1.8, p = 0.004), while those with a previous history of adherence were more likely to remain compliant (OR = 1.7, p = 0.012), as shown in Table 5
Starting any of these medications can feel daunting
Sleep, 33(12), 1605-1614
Many patients find it less uncomfortable than the abdomen once theyve gotten the hang of it
